Risk factor study of endometrial hyperplasia

Abstract

Introduction: Menorrhagia accounts for 18.5% of gynecologist ofÏce visits in the United States and for 20% in the United Kingdom, more than 5% of women who are 30 to 49 years of age consult family physicians each year in the United Kingdom with this problem.⁵ Rates of surgical procedures for menorrhagia are 17.8 per 10,000 women 25 to 44 years of age in the United States and 14.3 per 10,000 women 24 to 59 years of age in the United Kingdom. Only about half the women with menorrhagia who present to healthcare providers have blood loss greater than the traditional clinical threshold of 80 ml per menstrual cycle. Surgery is considered the therapy of choice for AH (atypical hyperplasia), in light of the lower risk of developing malignancy women with HMB should initially be managed by remote communication. They should be reassured that the risk of malignancy is negligible [15]. A relevant clinical history should be taken to elucidate the severity of the symptoms, the possibility of anemia and the likely cause. However, accurately measuring the degree of blood loss remains important as it provides a valuable tool for the measurement of response to treatment, and in research, where the validity of results depends on the accuracy of blood loss measurement. Currently, the incidence of endometrial hyperplasia (EH) is indistinctly reported to be around 200000 new endometrial hyperplasia (EH) cases per year in Western countries. Background: Women complaining of menorrhagia case group (55), control group 54 were studied in the First maternity hospital. Methods: Women aged 25–55 years with low or medium risk menorrhagia. Those with no demonstrable gynecological pathology had their menstrual blood loss. Informed consent was obtained from all individual participants included in the study. Since the study was approved ethics committee of MNUMS. Patients were also asked to report any hospitalizations and adverse events leading to discontinuation of the study. Results: The average endometrial thickness of the in women with diabetes mellitus is 15.3±5.8 millimeters, and in women with PCOS it is 16.2±4.6 millimeters, which is relatively high. 69.09% of the participants had prolonged menstruation more 8 days, 67.27% had a menstrual cycle infrequent more than 10 days, 90.91% had a menstrual flow volume more than 80 milliliters, and 43.64% had sudden random bleeding after many months. Conclusion: Our study, similar to that of Korean scientists Vishal Chandra and Jong Joo Kim, differed in that age factors (p=0.145) did not directly affect the endometrial thickness of the due to natural risk factors (p=0.0039). Our study found that EH is associated with estrogen-induced disorders.